Results 241 to 250 of about 634,950 (338)

The geo-politics of resilience: On the historical convergence between ecology, artificial intelligence, and corporate strategy. [PDF]

New Media Soc
Halpern O.
europepmc   +1 more source

THE DIGITAL MARKETS ACT: ENSURING MORE CONTESTABILITY AND OPENNESS IN THE EUROPEAN DIGITAL MARKET

InterEULawEast journal for the international and european law economics and market integrations
Ana Pošćić
semanticscholar   +1 more source

Operationalizing BioSSbD: A safe‐and‐sustainable‐by‐design framework for biorefineries

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biorefineries are central to the transition toward a circular bioeconomy; however, their increasing scale and technological heterogeneity, and the integration of biological, chemical, and thermochemical processes introduce complex challenges related to safety, sustainability, and operational reliability. Existing Safe‐and‐Sustainable‐by‐Design
Fernando Ramonet
wiley   +1 more source

Balancing Innovation and Control: The European Union AI Act in an Era of Global Uncertainty. [PDF]

JMIR AI
Bignami EG, Russo M, Semeraro F, Bellini V.   +3 more
europepmc   +1 more source

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi, Heleen van der Sijs, Floor van Rosse   +2 more
wiley   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Cross-Sectional Study on Oral Nicotine Product Sales Trends in Scandinavia From 2018 to 2025.

JMIR Public Health Surveill
Murphy MA, Henenberg D, Reese L.
europepmc   +1 more source

Adaptability factors and behavioral biases of investors in frontier markets: An adaptive market hypothesis perspective. [PDF]

PLoS One
Jannatunnesa J, Mahdzan NS, Md Noman AH.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Expanding risks: Medicaid expansion and data security. [PDF]

PLoS One
Clement J, Greenwood BN, D'Arcy J, Angst C.   +3 more
europepmc   +1 more source